167 related articles for article (PubMed ID: 9132444)
21. Sodium and water retention in heart failure: pathogenesis and treatment.
Martin PY; Schrier RW
Kidney Int Suppl; 1997 Jun; 59():S57-61. PubMed ID: 9185106
[TBL] [Abstract][Full Text] [Related]
22. Aldosterone in congestive heart failure.
Weber KT
N Engl J Med; 2001 Dec; 345(23):1689-97. PubMed ID: 11759649
[No Abstract] [Full Text] [Related]
23. [Congestive heart failure].
Yamazaki N
Nihon Rinsho; 1974 Aug; 32(8):2629-35. PubMed ID: 4373601
[No Abstract] [Full Text] [Related]
24. Effects of neural and humoral agents on the renal tubules in congestive heart failure.
Rouse D; Suki WN
Semin Nephrol; 1994 Sep; 14(5):412-26. PubMed ID: 7997648
[No Abstract] [Full Text] [Related]
25. [Current aspects of tissue renin-angiotensin systems: atrial natriuretic peptide and prostaglandins in arterial hypertension].
Ferreira Montero IJ
Rev Esp Cardiol; 1990; 43 Suppl 1():24-33. PubMed ID: 2139975
[TBL] [Abstract][Full Text] [Related]
26. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
27. Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
Packer M
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):66-73. PubMed ID: 3037891
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology of sodium and water retention in heart failure.
Cadnapaphornchai MA; Gurevich AK; Weinberger HD; Schrier RW
Cardiology; 2001; 96(3-4):122-31. PubMed ID: 11805379
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the renin-angiotensin system by atrial natriuretic peptide.
Johnston CI; Phillips PA; Arnolda L; Mooser V
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S43-6. PubMed ID: 1708022
[TBL] [Abstract][Full Text] [Related]
30. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
31. Regulation of proximal tubule sodium reabsorption by angiotensin II (AII) and atrial natriuretic factor (ANF).
Harris PJ; Thomas D; Zhuo J; Skinner SL
Acta Physiol Scand Suppl; 1990; 591():63-5. PubMed ID: 2145724
[No Abstract] [Full Text] [Related]
32. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
33. [Renin-angiotensin-aldosterone system and natriuretic peptide system--reference to cardiovascular diseases].
Yasue H; Mizuno Y; Harada E; Ito T
Nihon Rinsho; 2004 Sep; 62 Suppl 9():164-9. PubMed ID: 15506362
[No Abstract] [Full Text] [Related]
34. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
[TBL] [Abstract][Full Text] [Related]
35. [Vasopeptidase inhibitors. Clinical implications of a new class of drugs].
Quaschning T; Corti R; Ruschitzka FT; Noll G; Lüscher TF
Dtsch Med Wochenschr; 2000 Apr; 125(16):499-503. PubMed ID: 10819011
[No Abstract] [Full Text] [Related]
36. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
[TBL] [Abstract][Full Text] [Related]
37. [Nephrological aspects of congestive cardiac failure].
Moiseev SV; Fomin VV
Ter Arkh; 2003; 75(6):84-9. PubMed ID: 12920968
[No Abstract] [Full Text] [Related]
38. B-type natriuretic peptide: from bench to bedside.
Adams KF; Mathur VS; Gheorghiade M
Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450
[No Abstract] [Full Text] [Related]
39. Evolution of angiotensin-converting enzyme inhibitors.
Wyvratt MJ
Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
[TBL] [Abstract][Full Text] [Related]
40. [Non-modulating essential hypertension].
Mohara O; Masuyama Y
Nihon Rinsho; 1992 May; 50 Suppl():512-6. PubMed ID: 1512989
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
